Member Info for Servalan

6 weeks since rat. I thought I'd be celebrating, at least progress if not share price by now. Now it's how to get past a supposedly trustworthy partner ck blocking a lithium mine in this market. Farcical.

Appreciate your commentary BigBiteNow :-)

TheMillipede - you have a very good understanding of all of this, and Shield in general. Do you think Shield is a now takeover target? I'm surprised it hasn't happened already tbh. Especially now the numbers are trending (NY changes considered) in the right direction finally.

Seems like an over reaction at the open. Not bothered about the CFO, it's a small biotech and not a job for life. If he has moved on that's fine, no evidence yet of any bad reason. The NY situation is more concerning but they dance to their own tune there. The overall trend over the year is clearly in the right direction and they have done well to turn things around. I'm moving from buy to hold.

Down 10.5% and there are "more buys than sells" ?

Rx NHS England Feb 2026: £162,446 (Feb 2025: £111,822) over 45% yoy increase !

(open prescribing dot net)

I also don't care if it is "baseless" or a lie or whatever. Probably just a generic response to all emailers to IR. I'm ok to hold here as it will happen eventually, I just expected too much too soon after the rat.

EarEyeAm:

From Henry Wilkinson at Atlantic. Email him yourself and you will get the same response, subject to nothing changing on Monday.

"The Company’s proposed pathway to advance the Project has been submitted to the Project’s Technical Committee (comprised equally of representatives from Atlantic Lithium and Elevra) but remains under discussion. Progression on the proposed pathway is subject to unanimous approval by the Technical Committee. Once these discussions have concluded, we expect to be in a position to provide an update to shareholders."

Time for them to s**t or get off the can, as they say.

5 weeks of silence. I can't even get away with sulking that long at home.

That was the exact same reply I received. So not a lie at all Jack.

It needs unanimous approval from the Technical Committee. That committee is made up of equal parts Atlantic & Elevra.

No, not a lie. I posted it in full earlier - it was removed by the moderators here. Email IR yourself. Surprised more people haven't. Anyway, it's just more waiting. We are all used to that by now.

That is what I was told by IR. Email them and get a response from Henry. I'm not allowed to re-post it here.

My earlier post on the response from IR was removed as it is against rules to post direct communication. Fair enough. The gist was, it's Elevra holding this up as it is not one of their "priorities". You'd think there would have been a plan in place agreed by all parties ready to go after rat. They had plenty of time. The wait goes on and the SP drops in the meantime. All a bit strange. I'm not buying any more until I get an update from them.

Yep. Steady progress being made here. Hopefully it will get some industry attention and they are snapped up by a larger pharma.

Can't even hold 15p on a market day like today! what the actual f is going on with this now. What is their plan, what are their next steps? Missing out on a ton of opportunities elsewhere holding this now.

This share price post-rat must be an April Fool

Rx NHS England Jan 2026: £162,753 (Jan 2025: £116,018) a 40% yoy increase !

(open prescribing dot net)

it never seems to hold back any ****ty little gold miner shooting up 100s of % when they find so much as a sliver of yellow and then it turns out to be an old crunchie wrapper.